Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1938 results

LSPN Connect: Challenges in the US patent landscape

US21-09-2020Muireann Bolger

Innovations in life sciences have dramatically advanced the quality of US healthcare, while diagnostic tests and drug therapies that once seemed beyond our grasp have now become standard.

Merck & Co to buy $1bn stake in Seattle Genetics

US16-09-2020Sarah Morgan

Merck & Co is set to make a $1 billion investment in biotech company Seattle Genetics, as the companies collaborate to develop and sell Seattle Genetics’ cancer therapy, ladiratuzumab vedotin.

Orexo sues Sun Pharma over opioid dependence generic

Sweden, US16-09-2020Sarah Morgan

Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.

Judge gives initial approval to Actavis $20m antitrust deal

US15-09-2020Sarah Morgan

A Massachusetts judge has provided her preliminary approval to a $19.9 million settlement in a class action antitrust suit brought against pharmaceutical company Actavis. 

Broad and ERS Genomics both claim victory in latest CRISPR ruling

US14-09-2020Sarah Morgan

The Broad Institute and ERS Genomics, a company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, have both claimed victory in the latest round of the CRISPR inventorship battle.

Gilead to buy Immunomedics for $21bn

US14-09-2020Sarah Morgan

Gilead Sciences is set to acquire biopharmaceutical company Immunomedics in a $21 billion deal, further strengthening its oncology expertise.

Amyris facing $881m lawsuit over claims it broke contract

US11-09-2020Rory O'Neill

Cannabinoid maker Lavvan has filed a $881 million trade secrets lawsuit against pharmaceutical company Amyris.

Ruling opens door for Noven’s oestrogen patch generics

US10-09-2020Sarah Morgan

In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Fed Circ grants Arthrex remand, rejects Iancu conflict

US10-09-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.

CRISPR babies still too risky, warns new report

US10-09-2020Legal developmentsMuireann Bolger

Human embryos whose genomes have been edited should not be used to create a pregnancy until it is certain that changes can be made without introducing undesired changes, according to a new report by an influential panel. 

Showing 1 to 10 of 1938 results